MASTERINVEST Kapitalanlage GmbH Acquires New Stake in HCA Healthcare, Inc. $HCA

MASTERINVEST Kapitalanlage GmbH purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel.com reports. The institutional investor purchased 1,877 shares of the company’s stock, valued at approximately $732,000.

Several other institutional investors have also added to or reduced their stakes in the stock. BlackRock Inc. bought a new position in HCA Healthcare during the 2nd quarter worth approximately $5,069,974,000. Norges Bank acquired a new stake in shares of HCA Healthcare during the fourth quarter worth $1,262,513,000. Legal & General Group Plc acquired a new position in HCA Healthcare in the second quarter valued at $410,992,000. Jupiter Topco LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $371,138,000. Finally, Life Cycle Investment Partners Ltd bought a new stake in HCA Healthcare in the fourth quarter worth approximately $374,037,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Argus lowered their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Cantor Fitzgerald decreased their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Morgan Stanley decreased their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating for the company in a report on Monday, July 27th. Finally, Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Fourteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $462.64.

HCA Healthcare Trading Down 0.4%

Shares of HCA Healthcare stock opened at $417.57 on Friday. The firm has a market capitalization of $90.40 billion, a P/E ratio of 13.98, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The business’s fifty day simple moving average is $401.08 and its 200 day simple moving average is $441.46.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $6.84 EPS. Analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.